Metabolic perturbations sensitize triple-negative breast cancers to apoptosis induced by BH3 mimetics
3D modeling of cancer stem cell niche | Oncotarget
Medical Sciences | Free Full-Text | Colorectal Cancer: Genetic Abnormalities, Tumor Progression, Tumor Heterogeneity, Clonal Evolution and Tumor-Initiating Cells | HTML
Microbiology and Molecular Biology Reviews Journal Homepage
Phagocytosis by stroma confounds coculture studies - ScienceDirect
No immediate threat from delta plus variant in places that had delta variant outbreaks, says CSIR expert - The Hindu
Microbiology and Molecular Biology Reviews Journal Homepage
Mechanisms of apoptosis-induction by rottlerin: therapeutic implications for B-CLL | Leukemia
Epidemiology and Management of Hepatocellular Carcinoma - Gastroenterology
Precision medicine for human cancers with Notch signaling dysregulation (Review)
Frontiers | Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles | Oncology
Cancers | Free Full-Text | Targeting the Hippo Pathway for Breast Cancer Therapy | HTML
The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL | Leukemia
The phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia - ScienceDirect
The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL | Leukemia
Scadden Lab | HSCRB
Microbiology and Molecular Biology Reviews Journal Homepage
The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL | Leukemia
Will Your Vaccine Work Against Delta? - Bloomberg
Bruton's tyrosine kinase inhibition increases BCL-2 dependence and enhances sensitivity to venetoclax in chronic lymphocytic leukemia | Leukemia
Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies: Trends in Pharmacological Sciences
Stereotypical Chronic Lymphocytic Leukemia B-Cell Receptors Recognize Survival Promoting Antigens on Stromal Cells
New Approaches to SCLC Therapy: From the Laboratory to the Clinic - Journal of Thoracic Oncology
Epidemiology and Management of Hepatocellular Carcinoma - Gastroenterology
The Stromal Microenvironment Modulates Mitochondrial Oxidative Phosphorylation in Chronic Lymphocytic Leukemia Cells - ScienceDirect
Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer | Clinical Cancer Research
Metabolic perturbations sensitize triple-negative breast cancers to apoptosis induced by BH3 mimetics
Expression and function of phosphoinositide 3‐kinase delta in mesenchymal stromal cells from normal and leukaemic bone marrow - Ali - 2019 - British Journal of Haematology - Wiley Online Library
